Phenominer Database Results (16 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Value Units SEM SD Method Method Duration Post Insult Time Value Experiment Notes Record ID Study ID
FHH-Chr XBN/Mcwi percent change in arterial blood flow rate controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) PhysGen Cardiac data arterial blood flow trait male 49 days-63 days 7 post-ischemic value/pre-ischemic value x 100% 42.76 % 2.99 7.91 isolated perfused heart effluent collection 0 Moms and pups used in studies were fed Teklad 47073 461
FHH-Chr XBN/Mcwi percent change in arterial blood flow rate controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) PhysGen Cardiac data arterial blood flow trait female 49 days-63 days 7 post-ischemic value/pre-ischemic value x 100% 68.56 % 10.42 27.56 isolated perfused heart effluent collection 0 Moms and pups used in studies were fed Teklad 46066 461
FHH-Chr XBN/Mcwi arterial blood flow rate controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) PhysGen Cardiac data arterial blood flow trait male 49 days-63 days 9 5.38 ml/min/g 0.97 2.9 isolated perfused heart effluent collection 0 Moms and pups used in studies were fed Teklad 46197 461
FHH-Chr XBN/Mcwi arterial blood flow rate controlled oxygen content Kreb's solution perfusate (for 0.5 hours) PhysGen Cardiac data arterial blood flow trait female 49 days-63 days 6 7.34 ml/min/g 0.55 1.35 isolated perfused heart effluent collection 0 Moms and pups used in studies were fed Teklad 46870 461
FHH-Chr XBN/Mcwi heart effluent lactate dehydrogenase activity level normalized to heart weight controlled oxygen content Kreb's solution perfusate (for 0.5 hours) PhysGen Cardiac data heart lactate dehydrogenase activity male 49 days-63 days 10 0.42 IU/g 0.07 0.23 isolated perfused heart effluent collection 0 Moms and pups used in studies were fed Teklad 47313 461
FHH-Chr XBN/Mcwi arterial blood flow rate controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) PhysGen Cardiac data arterial blood flow trait female 49 days-63 days 6 4.24 ml/min/g 0.28 0.68 isolated perfused heart effluent collection 0 Moms and pups used in studies were fed Teklad 46201 461
FHH-Chr XBN/Mcwi arterial blood flow rate controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) PhysGen Cardiac data arterial blood flow trait female 49 days-63 days 8 4.2 ml/min/g 0.25 0.71 isolated perfused heart effluent collection 0 Moms and pups used in studies were fed Teklad 44718 461
FHH-Chr XBN/Mcwi heart effluent lactate dehydrogenase activity level normalized to heart weight controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) PhysGen Cardiac data heart lactate dehydrogenase activity female 49 days-63 days 7 9.73 IU/g 1.32 3.48 isolated perfused heart effluent collection 0 Moms and pups used in studies were fed Teklad 48866 461
FHH-Chr XBN/Mcwi arterial blood flow rate controlled oxygen content Kreb's solution perfusate (for 0.5 hours) PhysGen Cardiac data arterial blood flow trait male 49 days-63 days 10 9.56 ml/min/g 1.49 4.7 isolated perfused heart effluent collection 0 Moms and pups used in studies were fed Teklad 46866 461
FHH-Chr XBN/Mcwi arterial blood flow rate controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) PhysGen Cardiac data arterial blood flow trait male 49 days-63 days 8 9.91 ml/min/g 0.77 2.18 isolated perfused heart effluent collection 0 Moms and pups used in studies were fed Teklad 46649 461
FHH-Chr XBN/Mcwi arterial blood flow rate controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) PhysGen Cardiac data arterial blood flow trait female 49 days-63 days 8 9.51 ml/min/g 0.72 2.03 isolated perfused heart effluent collection 0 Moms and pups used in studies were fed Teklad 46653 461
FHH-Chr XBN/Mcwi heart effluent lactate dehydrogenase activity level normalized to heart weight controlled oxygen content Kreb's solution perfusate (for 0.5 hours) PhysGen Cardiac data heart lactate dehydrogenase activity female 49 days-63 days 7 0.46 IU/g 0.12 0.32 isolated perfused heart effluent collection 0 Moms and pups used in studies were fed Teklad 47317 461
FHH-Chr XBN/Mcwi percent change in arterial blood flow rate controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) PhysGen Cardiac data arterial blood flow trait male 49 days-63 days 9 post-ischemic value/pre-ischemic value x 100% 59.69 % 12.7 38.11 isolated perfused heart effluent collection 0 Moms and pups used in studies were fed Teklad 46062 461
FHH-Chr XBN/Mcwi heart effluent lactate dehydrogenase activity level normalized to heart weight controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) PhysGen Cardiac data heart lactate dehydrogenase activity male 49 days-63 days 9 15.59 IU/g 3.12 9.37 isolated perfused heart effluent collection 0 Moms and pups used in studies were fed Teklad 48863 461
FHH-Chr XBN/Mcwi arterial blood flow rate controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) PhysGen Cardiac data arterial blood flow trait male 49 days-63 days 7 4.15 ml/min/g 0.36 0.96 isolated perfused heart effluent collection 0 Moms and pups used in studies were fed Teklad 44714 461
FHH-Chr XBN/Mcwi percent change in arterial blood flow rate controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) PhysGen Cardiac data arterial blood flow trait female 49 days-63 days 8 post-ischemic value/pre-ischemic value x 100% 45.1 % 2.68 7.57 isolated perfused heart effluent collection 0 Moms and pups used in studies were fed Teklad 47077 461